Канада - Енглески - Health Canada

teva canada limited - bismuth subsalicylate - tablet (chewable) - 262mg - bismuth subsalicylate 262mg - antacids and adsorbents

Канада - Енглески - Health Canada

actavis pharma company - bismuth subsalicylate - suspension - 17.5mg - bismuth subsalicylate 17.5mg - antacids and adsorbents

Канада - Енглески - Health Canada

crls - bismuth subsalicylate - suspension - 35.2mg - bismuth subsalicylate 35.2mg - antacids and adsorbents

Канада - Енглески - Health Canada

juno otc inc - bismuth subsalicylate - tablet - 262mg - bismuth subsalicylate 262mg - antacids and adsorbents

Канада - Енглески - Health Canada

juno otc inc - bismuth subsalicylate - tablet (chewable) - 262mg - bismuth subsalicylate 262mg - antacids and adsorbents

Сједињене Америчке Државе - Енглески - NLM (National Library of Medicine)

h2-pharma, llc - bismuth subcitrate potassium (unii: r3o80h60kx) (bismuth cation - unii:zs9cd1i8ye), metronidazole (unii: 140qmo216e) (metronidazole - unii:140qmo216e), tetracycline hydrochloride (unii: p6r62377kv) (tetracycline - unii:f8vb5m810t) - bismuth subcitrate potassium, metronidazole and tetracycline hydrochloride capsules in combination with omeprazole are indicated for the treatment of patients with helicobacter pylori infection and duodenal ulcer disease (active or history of within the past 5 years) to eradicate h. pylori . the eradication of helicobacter pylori has been shown to reduce the risk of duodenal ulcer recurrence. to reduce the development of drug-resistant bacteria and maintain the effectiveness of bismuth subcitrate potassium, metronidazole and tetracycline hydrochloride capsules and other antibacterial drugs, bismuth subcitrate potassium, metronidazole and tetracycline hydrochloride capsules should be used to treat only indicated infections that are proven or strongly suspected to be caused by susceptible bacteria. when culture and susceptibility information are available, they should be considered in selecting or modifying antibacterial therapy. in the absence of such data, local epidemiology and susceptibility patterns may

Нови Зеланд - Енглески - Medsafe (Medicines Safety Authority)

psm healthcare ltd trading as api consumer brands - bismuth subgallate 100% - powder for oral solution - 100 % - active: bismuth subgallate 100%

Сједињене Америчке Државе - Енглески - NLM (National Library of Medicine)

allergan, inc. - bismuth subcitrate potassium (unii: r3o80h60kx) (bismuth cation - unii:zs9cd1i8ye), metronidazole (unii: 140qmo216e) (metronidazole - unii:140qmo216e), tetracycline hydrochloride (unii: p6r62377kv) (tetracycline - unii:f8vb5m810t) - bismuth subcitrate potassium 140 mg - pylera in combination with omeprazole are indicated for the treatment of patients with  helicobacter pylori infection and duodenal ulcer disease (active or history of within the past 5 years) to eradicate h. pylori . the eradication of helicobacter pylori   has been shown to reduce the risk of duodenal ulcer recurrence. to reduce the development of drug-resistant bacteria and maintain the effectiveness of pylera and other antibacterial drugs, pylera should be used to treat only indicated infections that are proven or strongly suspected to be caused by susceptible bacteria. when culture and susceptibility information are available, they should be considered in selecting or modifying antibacterial therapy. in the absence of such data, local epidemiology and susceptibility patterns may contribute to the empiric selection of therapy. do not administer methoxyflurane to patients taking pylera. the concurrent use of tetracycline hydrochloride, a component of pylera, with methoxyflurane has been reported to res

Сједињене Америчке Државе - Енглески - NLM (National Library of Medicine)

nich marketers, inc - bismuth subsalicylate (unii: 62tey51rr1) (bismuth cation - unii:zs9cd1i8ye), kaolin (unii: 24h4nwx5co) (kaolin - unii:24h4nwx5co) - bismuth subsalicylate 262 mg in 15 ml - indications: for oral use as an aid in relief of upset stomach, nausea and diarrhea in large and small animals. do not use in cats. do not use in cows producing milk for human consumption. active ingredients: bismuth subsalicylate 262 mg / 15 ml kaolin 500 mg / 15 ml in a base containing: magnesium aluminum silicate, sodium saccharin, xanthan gum, fd c red 28, preservatives, flavor, magnesium trisilicate, water qs. for veterinary use only shake well before using keep out of reach of children store at room temperature 69 degrees to 77 degrees f (20 degrees to 25 degrees c) protect from freezing avoid excessive heat, over 104 degrees f (40 degrees c) caution: for veterinary use only recommended oral dosage of bis-co-sorb: foals: 1 oz (30ml) every 4 hours. maximum 6 doses every 24 hours. repeat as necessary, or as directed by veterinarian. calves: 1 oz (30ml) every 4 hours. maximum 6 doses every 24 hours. repeat as necessary, or as directed by veterinarian. sheep and goats: 1/2 oz (15ml) every 4 hours. ma

Сједињене Америчке Државе - Енглески - NLM (National Library of Medicine)

jomex international llc - bismuth subsalicylate (unii: 62tey51rr1) (salicylic acid - unii:o414pz4lpz) - bismuth subsalicylate 262 mg in 15 ml - upset stomach reliever and antidiarrheal uses    relieves  • diarrhea  • heartburn  • indigestion  • nausea  • upset stomach